Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ksenija Korotkaja"'
Autor:
Reinis Putralis, Ksenija Korotkaja, Martins Kaukulis, Zhanna Rudevica, Juris Jansons, Olga Nilova, Martins Rucins, Laura Krasnova, Ilona Domracheva, Mara Plotniece, Karlis Pajuste, Arkadij Sobolev, Felikss Rumnieks, Laura Bekere, Anna Zajakina, Aiva Plotniece, Gunars Duburs
Publikováno v:
Pharmaceuticals, Vol 16, Iss 9, p 1245 (2023)
A set of styrylpyridinium (SP) compounds was synthesised in order to study their spectroscopic and cell labelling properties. The compounds comprised different electron donating parts (julolidine, p-dimethylaminophenyl, p-methoxyphenyl, 3,4,5-trimeth
Externí odkaz:
https://doaj.org/article/c72d1fe3c07644e092e19883f53d7ef5
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 10763 (2023)
Reprogramming of tumor-associated macrophages (TAMs) is a promising strategy for cancer immunotherapy. Several studies have shown that cancer cells induce/support the formation of immunosuppressive TAMs phenotypes. However, the specific factors that
Externí odkaz:
https://doaj.org/article/01dbe7a313bc496092cc36532da5440b
Autor:
Ksenija Korotkaja, Anna Zajakina
Publikováno v:
Viruses, Vol 15, Iss 5, p 1060 (2023)
The quantification of viruses is necessary for both research and clinical applications. The methods available for RNA virus quantification possess several drawbacks, including sensitivity to inhibitors and the necessity of a standard curve generation
Externí odkaz:
https://doaj.org/article/0f9814835c8348c29134ecfde2a6e699
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2142 (2022)
Viral vectors have been widely investigated as tools for cancer immunotherapy. Although many preclinical studies demonstrate significant virus-mediated tumour inhibition in synergy with immune checkpoint molecules and other drugs, the clinical succes
Externí odkaz:
https://doaj.org/article/675280760b674933b34a86b7188923b9
Autor:
Olga Trofimova, Ksenija Korotkaja, Dace Skrastina, Juris Jansons, Karina Spunde, Maria Isaguliants, Anna Zajakina
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1247 (2021)
Interferon gamma (IFNg) is a pleiotropic cytokine that can potentially reprogram the tumor microenvironment; however, the antitumor immunomodulatory properties of IFNg still need to be validated due to variable therapeutic outcomes in preclinical and
Externí odkaz:
https://doaj.org/article/1674301669384b16bf69ae07dc1de4ce
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10763
Reprogramming of tumor-associated macrophages (TAMs) is a promising strategy for cancer immunotherapy. Several studies have shown that cancer cells induce/support the formation of immunosuppressive TAMs phenotypes. However, the specific factors that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::f8b347365cf41d2d13f50ac6e45171e0